Rebirth 1999: Opening the Age of Black Technology

Qu Ping soon followed Chen Xiao's request and immediately announced the relevant announcements and requirements for the global bidding of Changtian Technology's combined colony therapy and combined energy colony therapy.

At this moment, Bristol-Myers Squibb, Johnson & Johnson, Pfizer and other companies are still in Changzezhou and have not left.

The three companies did not expect that Changtian Technology would play this game.

However, this is an absolute positive for the three companies.

Everyone knows that combined colony therapy and combined energy bacteria therapy are unique monopoly technologies in the world. One can complete the treatment of severe lung diseases, and the other can solve the problem of diabetes from the root.

If you can get the right of agency, of course, it means endless wealth in the future!

What is the best money to make!

Of course, monopoly businesses are the most profitable.

After seeing the announcement of Changtian Technology, companies such as Bristol-Myers Squibb and Pfizer immediately returned to the United States to prepare relevant materials.

In fact, the conditions proposed by Changtian Technology are easy to meet, and the most difficult to meet is the medical access qualification of the United States.

But when it comes to money, everything is possible.

Pfizer thought about it.

On the one hand, Pfizer will definitely try to persuade the relevant departments in the United States, hoping that the combined colony therapy can be certified by the US FDA as soon as possible.

However, according to the efficiency of the United States, even if there are congressmen or capital to put pressure on the relevant departments of the United States, the process is very long.

Therefore, Pfizer is preparing with both hands. The second aspect is to go to the "colonial" Puerto Rico of the United States or the country of Mexico in the back garden, and first promote the treatment plan, so that the people in the United States can receive treatment.

Both Poland and Mexico are very close to the United States, and the laws here are not strict, so it is best to do things like medical care.

The solution is to think about it. What Pfizer wants now is to get the agency rights of Changtian Technology.

There are also companies such as Johnson & Johnson and Best Myers Squibb who have this idea. They hurried home and reported the relevant situation to the head office and prepared bidding materials.

Chen Xiao never thought that his own arrangement would break the legs of the top ten pharmaceutical companies in the world.

However, this arrangement of Changtian Technology has made the relevant domestic departments nervous!

The related papers and clinical experimental results of Changtian Technology's combined colony therapy and combined energy bacteria therapy have been repeatedly studied and discussed by relevant national departments, and finally hundreds of pages of research results have been obtained.

Hundreds of pages of research results are a waste of space to describe. It can be summed up in two words—

Bullshit!

After obtaining this result, the relevant departments immediately started the medical promotion program, included the two combined colony treatment plans of Changtian Technology into the general treatment plan, and applied to the superior to include the corresponding treatment costs into the medical insurance.

However, combined colony therapy is still relatively expensive, so it is not very realistic to cover it within a few years.

Even so, it's the best, if not the only way to treat severe lung disease and diabetes.

Therefore, the relevant departments were very nervous when they learned that Changtian Technology was going to sell the qualification of treatment agent. They were very worried that the relevant treatment technology would be mastered by the West again. The right to speak is lost.

Yang Kai, the person in charge of medical and health care, felt that he could not explain a word or two by calling Chen Xiao, so he quickly took the plane to Suzhou and Hangzhou with the team, and then called a special car from Suzhou and Hangzhou, and rushed to Changsha on the same day. Zezhou meets Chen Xiao.

Yang Kai came to Changze Island in person, which made Chen Xiao a little flattered.

Chen Xiao immediately received Yang Kai and his party grandly in the conference room, thinking that Yang Kai was coming to visit the life science and medical laboratory of Changtian Technology to explore the therapeutic effect of combined exercise therapy.

Who knows that Yang Kai does not go to the laboratory or the treatment center at all, because through the papers published by Changtian Technology and the social reactions of patients who have received treatment, Yang Kai knows that the therapy of Changtian Technology is absolutely true Effective.

Yang Kai waved his hand and said to Chen Xiao, "Mr. Chen, this time our team is not here to visit your laboratory, nor to question whether your therapy is compliant or effective."

"Since the country can allow you to open a treatment center in Changzezhou, so that you can treat patients on a large scale, it means that this treatment method is absolutely effective and approved by the state. We are here this time. We heard that your company will Sold the treatment rights to combined exercise therapy and wanted to know about it.”

Yang Kai took a sip of tea and said: "We have passed all the certification procedures for the combined colony therapy, and have planned to use this therapy as a standard therapy for severe lung diseases and diabetes, in the name of the national health department, to various countries across the country. Hospitals and treatment centers will carry out promotion, and at that time, we will also ask for your cooperation with Changtian Technology."

Chen Xiao probably knows the significance of this cooperation, which means that the combined colony therapy of Changtian Technology will be promoted nationwide in the form of official certification. It also means that the combination of this therapy can truly and thoroughly open up the domestic market.

In the future, Changtian Technology will be able to send medical personnel to each province to assist the hospitals in the subordinate cities of the province that are qualified to complete the combined colony therapy and complete related treatment activities.

Of course, Changtian Technology is sure to make the biggest profit.

Yang Kai said anxiously: "We are very clear that the combination of colony therapy is a major breakthrough in the biomedical field. The combination of colony therapy can completely and completely treat severe lung diseases, and the combination of energy bacteria can completely treat diabetes. This kind of treatment method is the first time in the history of international medicine, and we Xia people can have the right to speak!"

Yang Kai has worked in the health system for many years, and he is all too aware of the importance of this right to speak.

International biomedical technology develops collaboratively, and it is not a country or a company that can master the world's most advanced biomedical technology on its own.

But if you don't have a trump card in your hand, you are not qualified to negotiate with other countries at all. There are some indispensable life-saving treatments or drugs, and the other party can sell them to you at a high price regardless of your feelings, and you have no bargaining right.

But if you have one or two trump cards in your hand, you can negotiate with these Western countries and technology companies to form a win-win compromise for both parties.

In the past, there were few trump cards in the hands of Xia Guo's biomedical community, almost none. The so-called trump card was the large-scale market of Xia Guo.

Therefore, the targeted anti-cancer drugs and high-end medical equipment of Western technology companies, especially pharmaceutical companies in the United States, will be sold in Xia Guo at ridiculously high prices, and Xia Guo has no choice but to accept them all.

Looking at Yang Kai and Chen Xiao who were so anxious, he said with a smile: "Only the agency rights in the United States, not technology transfer!"

"And to tell you the truth, Changtian Technology has invested a lot of money in the research and development of chips, and also hopes to obtain cash flow at the fastest speed through technology transfer to support the development of the company."

Gu Yun

"We also hope to gain more voice for the national biomedical industry through this cooperation with U.S. pharmaceutical companies."

"If the country is willing, this time we can add a package of conditions to the negotiation with a company in the United States, including some necessary drugs and price reductions for medical devices, etc."

Hearing Chen Xiao say this, Yang Kai was really relieved.

Yang Kai thought for a while, and felt that what Chen Xiao said was very reasonable.

Let Xiaguo's biomedical technology go out and let overseas patients feel that Xiaguo's medical technology is no worse than theirs. Only in this way can we gradually accumulate the overseas reputation of Xiaguo's medical industry and make overseas critically ill patients inseparable. Kaixia country's medical technology and related drugs.

The two sides must have mutual needs to be able to further cooperate, and the relevant departments of Xia Guo will have a higher right to speak in the future when negotiating with the US pharmaceutical company.

Yang Kai said: "I will immediately formulate different package negotiation conditions for these three pharmaceutical companies."

Yang Kai has worked in the medical sector for many years and has dealt with companies such as Pfizer, Johnson & Johnson, and Bristol-Myers Squibb many times, so they are very familiar with the scarce resources that these pharmaceutical companies have.

For example, some high-end medical equipment, antiviral drugs, anticancer drugs, etc.

As long as Chen Xiao cooperates with any of these companies, Yang Kai will put forward different requirements for them, so as to satisfy the medical market of Xia Guo and save money for the country.

Chen Xiao and Yang Kai talked for a long time, and the two sides decided on the final plan.

When Yang Kai left, he was full of emotion, "If Xia Guo could have more technology companies like Changtian Technology, He Chou would not be able to speak in the international medical industry."

Changtian Technology also issued a supplementary agreement for the public bidding for overseas agency rights according to the results of discussions with relevant departments.

In addition to meeting the package negotiation conditions for Xiaguo's related medical products and medical equipment, the lowest price for agency rights is also given.

No matter which company wins the bid, it has to pay at least 3 billion yuan in agency fees. After the agency right, the profit will be divided into 50%.

The starting price of 3 billion meters was given by Chen Xiao after weighing.

Because in 2006, the sales of several companies such as Pfizer have exceeded 10 billion meters, of which Pfizer has reached 30 billion meters, and these companies invest billions of meters in research and development expenses every year.

Therefore, the agency fee of 3 billion knives is very uncomfortable for these companies, which is acceptable or unacceptable.

If you don't accept it, then huge profits in the future will fall into the hands of others, but if you accept it, it will be quite painful to take out 3 billion meters of knives.

After Changtian Technology announced a package of negotiating conditions, some of these pharmaceutical companies collapsed.

Cassien listened to the quarrel between the top management and shareholder representatives at the Best-Myers Squibb high-level meeting. After some quarrel, they still chose to compromise and were ready to accept the conditions of Changtian Technology.

But whether to invest 3 billion meters in the knife or 3 billion meters to go up, everyone is a little hesitant.

Because if the price happens to be reported as 3 billion yuan, and if Pfizer and other companies give 3 billion yuan or more, then Bristol-Myers Squibb will definitely not be able to win the bid.

The time for the battle of wits has begun.

Bristol-Myers Squibb, Pfizer, Johnson & Johnson and other companies have competition and cooperation in the pharmaceutical industry, but they are generally cooperative.

Especially in the international market, several pharmaceutical companies in the United States have cooperated with each other to seize the market with the capital support behind them.

For example, Pfizer developed a drug like Viagra to help men. This drug is very profitable, so companies such as Johnson & Johnson and Bristol-Myers Squibb will not develop similar drugs and cede the market to Pfizer.

Just as Bristol-Myers Squibb has developed an anti-hepatitis drug, Pfizer will be weaker in this regard, leaving the market to Bristol-Myers Squibb.

Now Changtian Technology makes these companies compare prices with each other, which really makes the three companies very painful.

In the end, Pfizer took the initiative to negotiate with Johnson & Johnson and Shiguibao respectively. Finally, the three parties decided to bid for Changtian Technology at a price of 3 billion meters. After obtaining the market in the United States, the three companies will be divided according to the proportion. agency.

One company paid 1 billion meters, which also eased the economic pressure of the three pharmaceutical companies.

In this way, the plan jointly drafted by the three companies was submitted to Changtian Technology.

After seeing this plan, Chen Xiao smiled and said: "They are doing this, I might as well not find an agent and continue to expand the therapy of combined colonies. At the treatment center in Xiaguo, we welcome more Americans to come. Xia Guo treatment, we can also build treatment centers in Mexico and other countries, so that it is closer to the United States."

Chen Xiao said so, but he knew that it was actually more difficult to operate, especially it was unrealistic to build a treatment center in Mexico. After all, Mexico is the back garden of the United States, and Changtian Technology has nothing to do with the United States. It will definitely be blocked in every possible way, and this kind of thing cannot be done.

But for businessmen, when negotiating, you must release all your words.

After learning that Changtian Technology was vetoed, the three parties immediately sent a delegation to negotiate with Changtian Technology.

Chen Xiao is also refreshing. Anyway, he built the hospital in the United States, and put the treatment technology in the United States to make money.

There is no essential difference between one agency and three agencies for Changtian Technology's profitability, so Chen Xiao said: "Three agencies are also fine~www.readwn.com~ The agency fee has risen to 3.3 billion meters, in addition, the other party must The package negotiation agreement given by Xia Guo compromises!"

The package negotiation agreement given by the relevant departments of Xia Guo includes the price reduction of Pfizer's Lipitor, Norvox, Celebrex, Viagra and other drugs, Bristol-Myers Squibb's ixabepilone, Dasatinib and other drugs and Johnson & Johnson's drugs and equipment.

The requirements of the relevant departments of Xia Guo are actually not high. It is not how low the medicines are, but the price level of these medicines is comparable to that of the United States or the European market.

After tough negotiations, on the National Day in 2007.

Changtian Technology has reached a cooperation agreement with three pharmaceutical companies participating in the United States.

The three pharmaceutical companies in the United States spent a total of 3.3 billion meters to obtain the agency rights of Changtian Technology's combined colony and combined energy bacteria therapy, and can carry out corresponding treatment in the United States and its territories.

After Yang Kai got the news in Yanjing, he raised his arms and shouted, and then burst into tears of excitement.